1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with globotriaosylceramide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergan, J; Grimmer, S; Raa, H; Sandvig, K; Schwudke, D; Shevchenko, A; Skotland, T; Wälchli, S | 1 |
| Dusny, S; Humpf, HU; Karch, H; Legros, N; Müthing, J; Pohlentz, G; Runde, J | 1 |
2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and globotriaosylceramide
| Article | Year |
|---|---|
Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin.
Topics: Animals; Biological Transport; Cell Line; Endosomes; Enzyme Inhibitors; Fumonisins; Glycosphingolipids; Golgi Apparatus; Humans; Lysosomal Membrane Proteins; Morpholines; Shiga Toxin; trans-Golgi Network; Trihexosylceramides; Vesicular Transport Proteins | 2009 |
Colocalization of receptors for Shiga toxins with lipid rafts in primary human renal glomerular endothelial cells and influence of D-PDMP on synthesis and distribution of glycosphingolipid receptors.
Topics: Cells, Cultured; Endothelial Cells; Glycosphingolipids; Humans; Kidney Glomerulus; Membrane Microdomains; Morpholines; Trihexosylceramides | 2017 |